Industry In The Middle: Merck's Frazier Takes A Stand, Trump Tweets Back

The US president made what seemed to be a retaliatory statement about high drug prices after Merck CEO Ken Frazier resigned from his jobs council.

Trump_Donald_160311_1200x675

By standing up for his personal values, Merck & Co. Inc. CEO Kenneth Frazier may have put the pharma industry – and high drug prices – back in President Trump's sightline.

Pharma industry leaders have been hesitant of speaking out against some of the president's more controversial initiatives and comments, but...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Leadership

More from Scrip